BJRI insider files Form 144 to sell 1,719 shares valued at $60,156
Rhea-AI Filing Summary
Form 144 notice for BJ's Restaurants, Inc. (BJRI) indicates a proposed sale of 1,719 common shares through Morgan Stanley Smith Barney on the NASDAQ with an aggregate market value of $60,155.72 and the issuer's outstanding shares listed as 22,124,179. The proposed approximate sale date is 08/15/2025. The filing shows the shares were acquired as 238 restricted stock on 09/09/2020 and 1,481 performance shares on 02/14/2024. The filer reports no securities sold in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and warns against intentional misstatements.
Positive
- None.
Negative
- None.
Insights
TL;DR Proposed sale of 1,719 shares (~$60k) by an insider via Morgan Stanley; size appears immaterial relative to outstanding shares.
The notice documents a routine Rule 144 sale submission for 1,719 common shares with an aggregate market value of $60,155.72 and an issuer outstanding share count of 22,124,179. Acquisition details show a mix of restricted stock and performance shares awarded in 2020 and 2024, which explains transferability under Rule 144. There are no reported sales in the prior three months, and the filer affirms no undisclosed material adverse information. From a securities perspective, the filing is a standard disclosure of intent to sell and does not, by itself, convey new operational or financial information about the issuer.
TL;DR Insider disclosure complies with Rule 144 formalities; transaction size is small and routine from a governance standpoint.
The form lists the broker, sale date, and acquisition history required for compliance. The mix of restricted and performance-based awards indicates typical executive compensation vesting and subsequent transferability. The signed representation regarding material information and the explicit broker identification reflect standard governance and disclosure practices. There is no indication of unusual disclosure, clustering of sales, or aggregated sales that would raise immediate governance concerns based on the data provided.